 |
(Photo=Bukwang Pharmaceutical) |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Bukwang Pharmaceutical held a board meeting on the 22nd and decided to retire 2.61 million shares of its own shares worth 50 billion won.
This is 3.67% of the total number of shares issued, which is equivalent to all of the shares held.
The decision was made after Lee Woo-hyun, chairman of the shareholders' meeting, expressed his commitment to shareholder return and value business, saying, "Bukwang Pharm is securing fiscal soundness through continuous high-intensity management improvement and will do its best to enhance shareholder value as well as turn it into a surplus this year to meet criticism from shareholders due to recent falling stock prices and poor performance."
AlphaBIZ Kim Jisun(stockmk2020@alphabiz.co.kr)
